Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms
Diabetologia · 2025
DOI: 10.1007/s00125-025-06643-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, 2025. Verfasst von Martina Chiriacò und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. martina.chiriaco@med.unipi.it. Hauptthemen laut MEDLINE: Obesity, Insulin, Overweight. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, Astra Zeneca.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS/HYPOTHESIS: Fasting hyperinsulinaemia is a key feature of obesity and is implicated in diabetes progression. However, the following aspects of insulin secretion remain unclear: (1) which index of obesity is most important; (2) what is the shape of the dose-response curve between obesity and insulin secretion; (3) what physiological mechanisms sustain insulin hypersecretion; (4) what are the underlying causes; and (5) whether sex-related differences exist. METHODS: We analysed data from 1250 healthy participants (547 men, 703 women) of the EGIR-RISC cohort followed up for 3.5 years, with age 30-60 years and BMI 18.5-40.0 kg/m2. Assessments included body composition, insulin secretion, beta cell function modelling from an OGTT and clamp-derived insulin sensitivity. Endogenous glucose production (EGP) was measured in a subset of 368 participants. Multivariable regression models and stratifications for BMI, body fat per cent, WHR and fat mass were applied to evaluate the effect of obesity on insulin secretion and beta cell function. RESULTS: The impact of obesity on fasting insulin secretion (FIS) was continuous across the full spectrum of BMI and WHR values and was greater in men than women. Among adiposity indices, fat mass (standardised β coefficient [Stβ] 0.27, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. martina.chiriaco@med.unipi.it.
- Sant'Anna School of Advanced Studies, Pisa, Italy. martina.chiriaco@med.unipi.it.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- School of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- Departamento de Salud Internacional, Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain.
- Sant'Anna School of Advanced Studies, Pisa, Italy.
Förderung
- European Commission
- Astra Zeneca
Zitieren
APA
Chiriacò, M., Tricò, D., Petrie, J. R., Gabriel, R., Gastaldelli, A., Nolan, J., Lalic, N., Mingrone, G., Mari, A., & Natali, A. (2025). Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms. Diabetologia. https://doi.org/10.1007/s00125-025-06643-9
Vancouver
Chiriacò M, Tricò D, Petrie JR, Gabriel R, Gastaldelli A, Nolan J, et al. Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms. Diabetologia. 2025. doi:10.1007/s00125-025-06643-9
BibTeX
@article{Chiriac2025,
author = {Chiriacò, Martina and Tricò, Domenico and Petrie, John R and Gabriel, Rafael and Gastaldelli, Amalia and Nolan, John and Lalic, Nebojsa and Mingrone, Geltrude and Mari, Andrea and Natali, Andrea},
title = {Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms},
journal = {Diabetologia},
year = {2025},
doi = {10.1007/s00125-025-06643-9}
}
EUVIMED